Avior Wealth Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,119
| Closed | -$344K | – | 2451 |
|
|
2024
Q4 | $344K | Sell |
4,119
-354
| -8% | -$29.6K | 0.01% | 553 |
|
|
2024
Q3 | $327K | Buy |
4,473
+131
| +3% | +$9.59K | 0.01% | 561 |
|
|
2024
Q2 | $297K | Buy |
4,342
+4,324
| +24,022% | +$296K | 0.01% | 573 |
|
|
2024
Q1 | $1.25K | Sell |
18
-42
| -70% | -$2.91K | ﹤0.01% | 2357 |
|
|
2023
Q4 | $4.3K | Hold |
60
| – | – | ﹤0.01% | 1187 |
|
|
2023
Q3 | $3.13K | Buy |
60
+18
| +43% | +$937 | ﹤0.01% | 1321 |
|
|
2023
Q2 | $2.66K | Hold |
42
| – | – | ﹤0.01% | 1324 |
|
|
2023
Q1 | $2.27K | Buy |
+42
| New | +$2.27K | ﹤0.01% | 1382 |
|